Tetsuji Tomita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tetsuji Tomita has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Eijiro Ohga
Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publicationMasao Yoshizumi
Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publicationTakahide Nagase
Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publicationYasuhiro Yamaguchi
Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publicationYasuyoshi Ouchi
Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publication
Latest Publications
- 1 December 2002
- Published by Wiley in Respirology
- Vol. 7 (4) , 305-310
Molecular mechanisms underlying human β‐defensin‐2 gene expression in a human airway cell line (LC2/ad)
Objective: Recently, human β‐defensin‐2 (hBD‐2), an inducible defensin, has been reported to be involved in innate immunity and host defence. To examine the exact roles of hBD‐2 in the respiratory system, we examined the molecular mechanisms of hBD‐2 gene expression in vitro.Methodology: Using a human airway cell line (LC‐2/ad), lipopolysaccharide (LPS)‐induced gene expression of hBD‐2 was studied in the absence or the presence of (i) dexamethasone, (ii) inhibition of NF‐κB and AP‐1, (iii) intracellular calcium chelator, and (iv) cyclooxygenase (COX) inhibitors.Results: Lipopolysaccharide‐induced gene expression of hBD‐2 was down‐regulated by (i) dexamethasone, (ii) inhibition of NF‐κB and AP‐1, and (iii) intracellular calcium chelator. However, COX inhibitors had no effect on LPS‐induced mRNA expression of hBD‐2.Conclusion: These findings suggest that glucocorticoids (GC), but not COX inhibitors, reduce hBD‐2 gene expression, while NF‐κB, AP‐1 and intracellular calcium are essential for hBD‐2 expression. Glucocorticoid‐induced down‐regulation of hBD‐2 might be involved in the GC‐induced suppression of respiratory host defence associated with hBD‐2.
- 1 December 2002
- Published by Wiley in Respirology
- Vol. 7 (4) , 305-310
Molecular mechanisms underlying human β‐defensin‐2 gene expression in a human airway cell line (LC2/ad)
Objective: Recently, human β‐defensin‐2 (hBD‐2), an inducible defensin, has been reported to be involved in innate immunity and host defence. To examine the exact roles of hBD‐2 in the respiratory system, we examined the molecular mechanisms of hBD‐2 gene expression in vitro.Methodology: Using a human airway cell line (LC‐2/ad), lipopolysaccharide (LPS)‐induced gene expression of hBD‐2 was studied in the absence or the presence of (i) dexamethasone, (ii) inhibition of NF‐κB and AP‐1, (iii) intracellular calcium chelator, and (iv) cyclooxygenase (COX) inhibitors.Results: Lipopolysaccharide‐induced gene expression of hBD‐2 was down‐regulated by (i) dexamethasone, (ii) inhibition of NF‐κB and AP‐1, and (iii) intracellular calcium chelator. However, COX inhibitors had no effect on LPS‐induced mRNA expression of hBD‐2.Conclusion: These findings suggest that glucocorticoids (GC), but not COX inhibitors, reduce hBD‐2 gene expression, while NF‐κB, AP‐1 and intracellular calcium are essential for hBD‐2 expression. Glucocorticoid‐induced down‐regulation of hBD‐2 might be involved in the GC‐induced suppression of respiratory host defence associated with hBD‐2.